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Heparan sulfate (HS) is a highly sulfated polysaccharide par-
ticipated in essential physiological functions from regulating
cell growth to blood coagulation. HS contains sulfated domains
known as N-S domains and low sulfate domains known as N-Ac
domains. Thedistributionof the domain structures is likely gov-
erned by the action of glucosaminyl N-deacetylase/N-sulfo-
transferase (NDST). Here, we sought to determine the substrate
specificity of NDST using model substrates and recombinant
NDST protein. We discovered that NDST-1 carries out the
modification in a highly ordered fashion. The enzyme sulfates
the substrate from the nonreducing end toward the reducing
end consecutively, leading to the product with a cluster of
N-sulfo glucosamine residues. Furthermore, a preexisting
N-sulfo glucosamine residue prevents the action of NDST-1 at
the residues immediately located at the nonreducing end, allow-
ing the formation of an N-Ac domain. Our results provide the
long sought evidence for understanding the formation of sul-
fated versus nonsulfated domains in the HS isolated from cells
and tissues. The study demonstrates the regulating role of
NDST-1 in mapping the sulfation patterns of HS.
Heparan sulfate (HS)2 is a highly sulfated linear polysaccha-
ride ubiquitously present on the cell surface and in the extra-
cellular matrix. HS plays essential roles in a wide variety of
biological processes, including assisting embryonic develop-
ment, inflammatory response, viral and bacterial infection, and
regulating blood coagulation (1). HS consists of a disaccharide
repeating unit of glucuronic acid (GlcA) or iduronic acid (IdoA)
and glucosamine, both capable of carrying sulfo groups. The
location of the sulfo groups and IdoA plays a crucial role in
determining the functions of HS (2). Structural analysis of HS
isolated fromnatural sources indicates that the sulfated saccha-
ride and IdoA residues are not evenly scattered along the poly-
saccharide, rather forming a cluster known as N-S domain (3).
These N-S domains are separated by the unsulfated saccharide
units known as N-Ac domain, referring to the domain contain-
ing a high level of GlcNAc residue (3). The N-S domain is
believed to exhibit the high binding affinity to proteins, and the
distribution of the N-S domain is proposed to be essential for
HS to display its full range of biological properties (4). However,
how to regulate the biosynthesis of HS with specific sulfation
patterns and the distribution of the N-S domains remains
unknown.
The biosynthesis of HS involves in building the polysaccha-
ride backbone as well as introducing sulfo groups and IdoA
residues. Multiple specialized enzymes, including HS polymer-
ase, sulfotransferases and epimerase, participate in the process
(Fig. 1). The synthesis is initiated from a tetrasaccharide (GlcA-
Gal-Gal-Xyl) that is attached to the core protein. HS polymer-
ase is responsible for building the polysaccharide backbone
with a repeating unit of -GlcA-GlcNAc-. The backbone is then
modified byN-deacetylase/N-sulfotransferase (NDST), C5-epi-
merase, 2-O-sulfotransferase, 6-O-sulfotransferase, and 3-O-
sulfotransferase. The substrate specificities of the biosynthetic
enzymes dictate the structures of HS product, including sulfa-
tion levels, the contents of IdoA units and the size of the poly-
saccharides (5). Understanding the biosynthetic mechanism of
HS is not only important for delineating the contribution of
structural selectivity of HS to the biological processes. The
knowledge also aids us to develop an enzyme-based approach
to synthesize HS-based therapeutics (6).
NDST catalyzes the conversion from a GlcNAc residue to a
N-sulfo glucosamine (GlcNS). NDST displays two activities:
N-deacetylase activity removes the acetyl group from the
GlcNAc residue to yield a GlcNH2 residue; N-sulfotransferase
activity transfers a sulfo group to the primary amine to form a
GlcNS residue. Total of four isoforms of NDST are present in
human genome (7, 8). Different isoforms are believed to exhibit
different substrate specificities, mainly differed in the ratio of
GlcNS/GlcNH2 and the length of the GlcNS domain (8).
Among them, NDST-1 exhibits profound physiological func-
tions and is themost widely expressed isoform. TheN-sulfation
is known to be perquisite for the subsequent epimerization and
2-O-sulfation, and possibly for 3-O-sulfation as demonstrated
by in vitro studies (9, 10, 12).3 In vivo, the functions of NDSTs
were discerned by gene knock-out experiments. NDST-2-null
mice appear to be normal, and the only abnormality seenwas in
connective tissue-type mast cells (13). The NDST-3 knock-out
mice are fertile, and exhibit only minor hematological and
behavioral phenotypes (14). Unlike other NDST isoforms, the
absence of NDST-1 inmice led to respiratory distress, and sub-
sequently neonatal death (15). Conditional knock-out of
NDST-1 revealed a series of physiological and pathophysiolog-
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ical roles, including the clearance of lipoproteins (16), the
development of lobuloalveolar ofmammary gland (17), neutro-
phil trafficking (18), and inhibition of tumor angiogenesis (19).
These in vivo effects of NDST-1 were attributed to the disrup-
tion of theN-sulfation, leading to dramatic changes inO-sulfa-
tions and epimerization of HS in genetically modified animals.
In this article, we studied NDST-1 using structurally defined
oligosaccharide substrates followed by the structural analysis
using electrospray ionization mass spectrometry (ESI-MS).
Our results demonstrate that NDST-1 can act on a substrate in
both random and nonrandom ways to yield the products with
different sulfation patterns. It appears that NDST-1 can ran-
domly choose to sulfate an internal GlcNAc residue. Once the
sulfation starts, the enzymes reacts with the substrate in a
highly ordered manner. NDST-1 sulfates consecutively from
nonreducing toward the reducing end to yield a cluster of
GlcNS residues, forming the anticipatedN-S domain. The pres-
ence of N-sulfo group prevents the N-sulfation at the immedi-
ate nonreducing residue, permitting the formation of the N-Ac
domain. Our results provide the long-sought biochemical evi-
dence to understand the causal role of NDST to synthesize
domain structures in HS.
EXPERIMENTAL PROCEDURES
Expression of NDST-1—The rat NDST-1 cDNA (R43-R882)
was cloned into pYES2 vector (Invitrogen) using the XbaI and
BglII sites to generate NDST-1 protein. The new recombinant
plasmid was named pYES2-NDST-1. The coding region of
expression plasmid was sequenced to confirm the reading
frame and absence of deleterious mutations (University of
North Carolina DNA sequencing facility). The pYES2-NDST-1
was transformed into the Saccharomyces cerevisiae InvSc1
(Invitrogen) using the S.c. Easy-Comp Transformation kit
(Invitrogen) according to the manufacturer’s instructions.
NDST-1 was expressed and purified as previously described
(20).
Modification of Oligosaccharides with NDST-1—As previ-
ously described (20), either heparosan or oligosaccharide sub-
strates were incubated with NDST-1 in a buffer containing 50
FIGURE 1. Biosynthetic pathway of HS. The biosynthesis of HS is initiated from a linkage region tetrasaccharide (GlcA-Gal-Gal-Xyl) that is attached to
the core protein, where GlcA, Gal, and Xyl represents glucuronic acid, galactose, and xylose, respectively. The polysaccharide backbone is then modified
by different HS biosynthetic enzymes as described in the text. The lack of modification by NDST results in the polysaccharide losing its biological
activities because the missing of 2-O-sulfation, epimerization, and 3-O-sulfation. The chemical structures of the disaccharide repeating unit of HS are
shown in the bottom. In the figure, R represents the core protein and the linkage region tetrasaccharide that is attached to the core protein, and R1
represents -H or -SO3.
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mM MES buffer, pH 6.5, 10 mM MnCl2, and PAPS (50 M) at
23 °C for 24 h.
Preparation of Size-defined N-Acetyl Heparosan Oligo-
saccharides—N-Acetyl heparosan polysaccharide was purified
from the overnight culture of E. coli K5 using a DEAE column
(21). As described by Sigulinsky et al. (22), the size-defined
N-acetyl heparosan oligosaccharides were prepared by partial
digestion using heparin lyase III. Heparosan polysaccharide
(5 mg) was incubated in 25 mM NaH2PO4, pH 7.0 at 37 °C for
24 h, using 2 g/ml heparin lyases III. Then, the N-acetyl
heparosan oligosaccharides of varying degree of polymeriza-
tion were separated and purified by fractionation on Bio-Gel
P10, which was eluted with a buffer containing 25 mM Tris
(pH 7.2) and 1000 mM NaCl at a flow rate of 6 ml/h. The
eluent was monitored by UV 232 nm. Fractions containing
size-defined N-acetyl heparosan oligosaccharides were
pooled and desalted by dialysis. The purity of the oligosac-
charides was confirmed by ESI-MS.
HPLC Analysis—To confirm the identity of NDST-1, the
recombinant protein was incubated with heparosan and PAPS.
The product was digested with heparin lyase III followed by a
disaccharide analysis using reverse phase ion pairing HPLC to
demonstrate the formation of the GlcNS-containing disaccha-
rides. The method was described in a report by Duncan et al.
(21). N-Sulfo oligosaccharides were analyzed and separated
on a DEAE column (4.6 mm ID  7.5 cm, Tosoh Bioscience),
which was eluted with a linear gradient of from 0 to 1 M NaCl
in 20 mM Tris-HCl (pH 7.0) over 80 min at a flow rate of
0.75 ml/min.
Microdialysis of Oligosaccharide—The oligosaccharides
were subjected to microdialysis prior to the MS analysis. The
dialysis was carried out using hollow fiber dialysis tubing
(13,000MWCO; Spectrum) against 20mM ammonium acetate.
Mass Spectrometry Analysis—MS analyses were performed
on a Thermo LCQ-Deca. The oligosaccharides were dissolved
in 50% methanol. A syringe pump (Harvard Apparatus) was
used to introduce the sample via direct infusion (35 l/min)
into the instrument. Experiments were performed in negative
ionization mode with a spray voltage at 3 KV and a capillary
temperature of 275 °C. The automatic gain control was set to
1  107 for full scan MS and 2  107 for MS/MS experiments.
For MS/MS experiments, selection of each precursor ion was
achieved using isolationwidth of 3Da and the activation energy
was 40% normalized collision energy. The product ions in
MS/MS data were labeled according to the Domon-Costello
nomenclature. The MS and MS/MS data were acquired and
processed using Xcalibur 1.3 software.
Preparation of Hexasaccharide 9, Decasaccharide 10, and
Dodecasaccharide 11—The hexasaccharide backbone with a
structure of GlcA-GlcNTFA-GlcA-GlcNAc-GlcA-AnMan was
elongated from a disaccharide, GlcA-AnMan, as described pre-
viously (12), where GlcNTFA represents N-trifluoroacetylated
glucosamine. The elongation as completed with UDP- mono-
saccharide donors (UDP-GlcNAc, UDP-GlcA, or UDP-N-trif-
luoroacetylated glucosamine (GlcNTFA)) and bacterial glyco-
syltransferases (KfiA or pmHS2) in the buffer containing 25mM
Tris-HCl (pH 7.2) and 10 mM MnCl2. The reaction was incu-
bated at room temperature for 16 h and analyzed by a poly-
amine-based HPLC column (from Waters) to ensure that
95% of UDP-monosaccharide donors was converted to UDP.
After elongating two monosaccharides, the reaction mixture
was resolved on a Bio-Gel P-2 column which was equilibrated
with 0.1 M ammonium bicarbonate at a flow rate of 3 ml/h. The
elution position of the product was determined byMS analysis.
The reaction cycles was repeated two times to prepare the hex-
asaccharide backbone.
The N-sulfation of the hexasaccharide backbone was com-
pleted by detrifluoroacetylation followed by N-sulfation. The
hexasaccharide backbone (5 mol) was dried and resuspended
in a solution (20 ml) containing CH3OH, H2O, and (C2H5)3N
(v/v/v, 2:2:1). The reaction was incubated at 37 °C for 6 h. The
samples were dried and reconstituted in H2O. The de-N-trif-
luoroacetylated hexasaccharide was incubated with N-sulfo-
transferase (180 g/ml) and 0.75 mM PAPS in a total volume of
20ml to yield hexasaccharide 9. The product was confirmed by
ESI-MS analysis. Further elongation of hexasaccharide 9 to
decasaccharide 10 and dodecasaccharide 11 was achieved by
KfiA and pmHS2 following essentially the same procedure.
RESULTS
Our efforts for determining the substrate specificity of
NDST-1 included the expression of recombinant NDST-1 pro-
tein and preparation of structurally defined oligosaccharide
substrates. A catalytic domain NDST-1, comprising of the
activities ofN-deacetylase andN-sulfotransferase, was success-
fully expressed in S. cerevisiae following the report by Saribas et
al. (20). Structurally defined oligosaccharide substrates were
isolated from partially depolymerized heparosan, a polysaccha-
ride with a repeating disaccharide of -GlcA-GlcNAc- (23). To
this end, heparosan was incubated with a limited amount of
heparin lyase III, and the depolymerized products were
resolved on size exclusion chromatography, Bio-Gel P-10 col-
umn. Total of five oligosaccharide substrates ranging fromhex-
asaccharide to dodecasaccharide, with a generic structure of
UA-(GlcNAc-GlcA)n-GlcNAc,were obtained. The structures
of the oligosaccharide substrates were confirmed by ESI-MS
(supplemental Table S1).
The availability of the structurally defined oligosaccha-
rides enabled us to determine the minimum size of the sub-
strate for NDST-1. The oligosaccharide substrates were
incubated with NDST-1and [35S]PAPS, and the products
were analyzed by DEAE-HPLC. Several 35S-labeled peaks
were detected as analyzed by DEAE-HPLC when octa-,
deca-, and dodecasaccharides were utilized, suggesting that
these oligosaccharides are the substrates for NDST-1 (Fig. 2,
B–D). In contrast, only a very small 35S-labeled peak was
observed from the hexasaccharide sample (Fig. 2A), suggest-
ing that hexasaccharide is not a good substrate for NDST-1.
Our results also suggest that octasaccharide is likely to be the
minimum size for NDST-1 to modify.
Using mass spectrometric techniques, we proved the struc-
tures of the NDST-1-modified oligosaccharides. We observed
two 35S-labeled peaks for octasaccharide eluted at 27.5 and 33.5
min (Fig. 2B), three for decasaccharide eluted at 36.5, 43.5, and
54.0 min (Fig. 2C), and three for dodecasaccharide eluted at
57.5, 66.0, and 75.0 min (Fig. 2C). These oligosaccharide prod-
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ucts were purified to homogeneity using DEAE-HPLC. An
example for proving the structure of octasaccharide 1 is shown
in Fig. 3 using ESI-MS and MS/MS techniques. The molecular
mass of octasaccharide 1was determined to be 1555.1 0.1Da,
very close to the calculated molecular mass for an octasaccha-
ride carrying a single sulfo group (1555.3 Da) (Fig. 3B). The
position of theN-sulfo group in octasaccharide 1was proved by
using a MS/MS technique, a condition that fragments the
octasaccharide at the glycolytic linkages. This MS/MS tech-
nique was successfully used to characterize the structure of
N-sulfated octasaccharides in our previous publication (12).
For example, two characteristic fragmented ions, Z4 and Z62,
at the m/z values of 757.4 and 586.7 provided the structural
evidence that the GlcNS residue is located at the designated
position of octasaccharide 1. Using similar techniques, we
proved the structures of remaining seven oligosaccharide prod-
ucts generated by NDST-1 (Table 1 and supplemental Figs.
S1–S7). Because only very small amount of 35S-labeled hexa-
saccharide was observed, we did not pursue to analyze its
structure.
Analysis of the structures of NDST-1-modified oligosac-
charides revealed unique N-sulfation patterns. First, the
N-sulfation site occurs five saccharide units from the reduc-
ing end. NDST-1 does not appear to prefer to a specific
GlcNAc in the substrate as long as it is located at certain
distant from the reducing end. By choosing different internal
GlcNAc sites to start the N-sulfation, NDST-1 modification
resulted in multiple products. Second, a cluster of N-sulfa-
tion was formed. Regardless of the size of the oligosaccharide
substrate, the products contained a cluster of the repeating
unit of -GlcA-GlcNS- unless only a single unit of -GlcA-
GlcNS- was present. At present time, the maximum size of
the cluster of N-sulfation domain generated by NDST-1
could not be determined due to the technical difficulty in
analyzing the structures larger than dodecasaccharide by
MS. Third, the N-sulfation by NDST-1 appears to occur in a
direction from the nonreducing end toward the reducing
end. This conclusion was drawn from our attempt to intro-
duce additional N-sulfo groups to those partially N-sulfated
oligosaccharides, i.e. conversion of octasaccharide 1 to
FIGURE 2. DEAE-HPLC profiles of NDST-1-modified oligosaccharides. The oligosaccharide substrates were incubated with NDST-1 and [35S]PAPS to yield
the 35S-labeled products. The products were purified by Bio-Gel P-10 and then subjected to the analysis by high resolution DEAE-HPLC. Panel A shows the
profile of using a hexasaccharide substrate. Panel B shows the profile of using an octasaccharide substrate. Panel C shows the profile of using a decasaccharide.
Panel D shows the profile of using a dodecasaccharide.
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octasaccharide 2. Continuing incubation of octasaccharide 1
with fresh batches of NDST-1 and PAPS failed to yield
octasaccharide 2, suggesting that octasaccharide 1 is no lon-
ger a substrate for NDST-1. Similarly, conversion of decasa-
ccharide 3 and 4, and dodecasaccharide 6 and 7 to decasac-
charide 5 and dodecasaccharide 8, respectively were also
unsuccessful. Our results suggest that the presence of a
GlcNS residue prevents the NDST-1 modification of the res-
FIGURE 3. Structural analysis of N-sulfo octasaccharide 1. A, reaction involved in the preparation of octasaccharide 1 and 2 by NDST-1. Non-radioactively
labeled octasaccharide 1 and 2 were prepared by using unlabeled PAPS and separated by DEAE-HPLC. The separation of octasaccharide 1 and 2 was achieved
by DEAE-HPLC as described in Fig. 2. B, ESI-MS spectrum of octasaccharide 1. C, MS/MS of octasaccharide 1. Precursor ion selection was at [M-3H]3, m/z 517.4.
The fragmentation pattern is depicted on the right. The conditions for MS and tandem MS analysis are described under “Experimental Procedures.” The
product ions in the MS/MS data were labeled according to the Domon-Costello nomenclature (11).
TABLE 1
Summary of the structures of NDST-1-modified products
Substrates Structures of the products Measured Calculated
MW (Da) MW (Da)
UA-(GlcNAc-GlcA)n-GlcNAca
n  2 No products N/A N/A
n  3
Octasaccharide 1 UA-GlcNAc-GlcA-GlcNS-GlcA-GlcNAc-GlcA-GlcNAc 1555.1  0.1 1555.3
Octasaccharide 2 UA-GlcNS-GlcA-GlcNS-GlcA-GlcNAc-GlcA-GlcNAcb 1593.9  0.9 1593.3
n  4
Decasaccharide 3 UA-GlcNAc-GlcA-GlcNAc-GlcA-GlcNS-GlcA-GlcNAc-GlcA-GlcNAc 1934.6  0.1 1934.6
Decasaccharide 4 UA-GlcNAc-GlcA-GlcNS-GlcA-GlcNS-GlcA-GlcNAc-GlcA-GlcNAc 1972.3  0.6 1972.6
Decasaccharide 5 UA-GlcNS-GlcA-GlcNS-GlcA-GlcNS-GlcA-GlcNAc-GlcA-GlcNAc 2010.7  0.1 2010.7
n  5
Dodecasaccharide 6 UA-GlcNAc-GlcA-GlcNAc-GlcA-GlcNS-GlcA-GlcNS-GlcA-GlcNAc-GlcA-GlcNAc 2351.8  0.8 2352.0
Dodecasaccharide 7 UA-GlcNAc-GlcA-GlcNS-GlcA-GlcNS-GlcA-GlcNS-GlcA-GlcNAc-GlcA-GlcNAc 2390.1  0.3 2390.9
Dodecasaccharide 8 UA-GlcNS-GlcA-GlcNS-GlcA-GlcNS-GlcA-GlcNS-GlcA-GlcNAc-GlcA-GlcNAc 2428.2  0.2 2428.0
a The oligosaccharide substrates were purified by a Bio-Gel P-10 column from partially heparin lyase III-digested heparosan. The structures of the substrates were confirmed
by ESI-MS.
b The position of the N-sulfo glucosamine in the products was determined by MS/MS as demonstrated in Fig 3 and supplemental Figs. S1 to S7. The N-sulfation sites are pre-
sented in bold face.
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idues immediately at its nonreducing end. This conclusion is
further strengthened by using a synthetic oligosaccharide
carrying an N-sulfo group as described below.
HS also contains N-Ac domain, a stretch of repeating disac-
charide of -GlcA-GlcNAc-, which is located between theN-sul-
fated domains. Our next goal was to determine if NDST-1 is
capable of generating the gap of N-Ac domain between two
GlcNS residues and the size of the nonsulfated gap. To achieve
this goal, we synthesized a hexasaccharide substrate, hexasac-
charide 9, with a structure of GlcA-GlcNS-GlcA-GlcNAc-
GlcA-AnMan. This hexasaccharide contained a GlcNS residue
near the nonreducing end that was synthesized using a che-
moenzymatic approach as described previously (12). Hexasac-
charide 9 was then elongated to a decasaccharide (decasaccha-
ride 10) and a dodecasaccharide (dodecasaccharide 11) using
two glycosyl transferases: KfiA of Escherichia coli, a N-acetyl
glucosaminyl transferase (24) and heparosan synthase 2 of Pas-
teurella multocida (pmHS2), an enzyme possessing a GlcA
transferase activity (25) (Fig. 4A). KfiA transfers a GlcNAc res-
idue to the reducing end of hexasaccharide 9 primer to form an
134 glycosylic linkage to yield a heptasaccharide. Further,
pmHS2 transfers a GlcA to the reducing end of the heptasac-
charide to form a 134 glycosylic linkage. Repeating the pro-
cess resulted in milligrams of decasaccharide 10 and dodecasa-
ccharide 11. The success for the synthesis of hexasaccharide 9,
decasaccharide 10, and dodecasaccharide 11was confirmed by
ESI-MS (supplemental Table S1).
Using the synthetic oligosaccharide substrates, we identified
the size of the N-Ac domain generated by NDST-1. Both
decasaccharide 10 and dodecasaccharide 11 were incubated
with NDST-1 and [35S]PAPS, and the products were analyzed
by Bio-Gel P10 (Fig. 4,C andD). Two substrates provided stark
contrast elution profiles from the P10 column. A clear 35S-la-
beled component was eluted at higher molecular weight range
in the reaction using dodecasaccharide 11 as a substrate (Fig.
4D). The 35S-labeled product was absent in the reaction using
decasaccharide 10 as a substrate (Fig. 4C), suggesting that no
reaction occurred.
The structure of NDST-1-modified dodecasaccharid 12
was determined by ESI-MS and MS/MS. First, DEAE-HPLC
analysis of NDST-1-modified dodecasaccharide revealed
that the product was eluted as a single symmetric peak, sug-
gesting only one product was formed after NDST-1 modifi-
cation (Fig. 5). Analysis of NDST-1-modified dodecasaccha-
ride 11 using MS and MS/MS confirmed its structure to be a
dodecasaccharide carrying two sulfo groups with a structure
of GlcA-GlcNS-GlcA-GlcNAc-GlcA-GlcNAc-GlcA-GlcNS-
GlcA-GlcNAc-GlcA-AnMan (Fig. 5). For example, ESI-MS
analysis revealed the molecular weight of dodecasaccharide 12 to
be 2313.7 0.7Da, very close to the calculatedmolecular of dode-
casaccharidecarrying twosulfogroups (calculated2312.9Da) (Fig.
5B).Meanwhile, twocharacteristic fragmented ionsof theMS/MS
analysis, B32 (m/z, 295.8) and C32 (m/z, 304.9) were observed.
The results suggest that the newly formed GlcNS residue was
located at the nonreducing end, and thus, the structure of dode-
casaccharide 12 was proven to be GlcA-GlcNS-GlcA-
GlcNAc-GlcA-GlcNAc-GlcA-GlcNS-GlcA-GlcNAc-GlcA-AnMan
(Fig. 5C). Taken together, our results demonstrate that the gap
of the N-Ac domain for NDST-1 should be at least five saccha-
ride residues.
DISCUSSION
NDST is the first modification enzyme in the HS biosyn-
thetic pathway. The actions of NDST determine the suscep-
FIGURE 4. Determination of the gap between GlcNS residues. A, scheme for the synthesis of decasaccharide 10 and dodecasaccharide 11 from hexasac-
charide 9. Hexasaccharide 9 was prepared using a chemoenzymatic approach as described under “Experimental Procedures”). The elongation of hexasaccha-
ride 9 to decasaccharide 10 and dodecasaccharide 11 were completed using KfiA and pmHS2. Both decasaccharide 10 and dodecasaccharide 11 were
incubated with NDST-1 and [35S]PAPS, and the products were analyzed by BioGel P-10. B, shows the elution profile of the reaction without an oligosaccharide
substrate. C, shows the elution profile of the reaction using decasaccharide 10 as a substrate. D, shows that elution profile of the reaction using dodecasac-
charide 11 as a substrate.
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tibility of subsequent modifications, especially for epimeri-
zation, 2-O- and 3-O-sulfation. Therefore, understanding
the substrate specificity of NDST becomes the center for
investigating the control of biosynthesis of HS. However,
several technical difficulties are associated with determining
the substrate specificity of NDST. For example, large size
oligosaccharide substrates are necessary for dissecting capa-
bility to create the N-S and N-Ac domains by the enzyme,
and these substrates are typically difficult to obtain. Further-
more, to pinpoint the location of the N-sulfo group in a large
oligosaccharide presents another technical challenge. Up to
date, the studies of substrate specificity of NDST have been
emphasized on using the polysaccharide substrate. The dis-
tribution of theN-sulfo groups was determined using nitrous
acid degradation, provided that GlcNS is susceptible to the
degradation by nitrous acid at pH 1.5, while the GlcNAc is
resistant to nitrous acid degradation. Carlsson et al. (26)
demonstrated that both NDST-1 and NDST-2 form a cluster
of -GlcA-GlcNS- repeating units using this approach. How-
ever, due to the structural heterogeneity of the polysaccha-
ride substrate, it is difficult to obtain a complete picture of
the role of NDST in mapping the N-S and N-Ac domains.
In this study, we utilized structurally defined oligosaccharides
and highly sensitive MS techniques to determine the substrate
specificity of NDST-1 with accuracy. Our results confirm that
NDST-1 generates a cluster of -GlcA-GlcNS- repeats. We also
observe the enzyme sulfates a GlcNAc residue very selectively
depending on the position in the oligosaccharide substrate and if a
GlcNS residue is in proximity. The results from our study uncov-
ered the mode of action of NDST-1 as illustrated in Fig. 6. In a
substrate that is absent of aGlcNS residue, the enzyme canbind to
any internal GlcNAc residue. Once the sulfation is initiated,
NDST-1 converts the GlcNAc to GlcNS residue consecutively
from nonreducing end to the reducing end until it reaches to the
residue that is five units away from the reducing end.Althoughwe
cannot determine the length of the cluster of GlcNS, we clearly
demonstrated thatNDST-1 is fully capableof generatingadomain
containing four repeats of -GlcA-GlcNS-.
The lack of the ability to initiate the N-sulfation at a specific
GlcNAc residue results in multiple products, consequently
leading to the structural heterogeneity during the biosynthesis
of HS (Fig. 6A). At present time, we did not observe the prefer-
ential binding NDST-1 to the GlcNAc residue within the sub-
strate. Thus, the initial binding process is likely to be random,
FIGURE 5. Structural characterization of dodecasaccharide 12. A, the DEAE-HPLC chromatogram of dodecasaccharide 12. The impurities were indicated.
B, the MS spectrum of dodecasaccharide 12. C, the MS/MS of dodecasaccharide 12. Precursor ion selection at [M-5H]5, m/z 461.9.
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allowing multiple products were produced even a single sub-
strate was introduced. One plausible approach to reduce the
product heterogeneity is to directNDST-1 to a specific GlcNAc
residue. Presto et al. (27) discovered the interaction of one HS
polymerase (EXT-2) and NDST-1. Interestingly, the authors
discovered that HS isolated HEK 293 cells overexpressing
EXT-2 was highly sulfated andmore closed to heparin than HS
(Heparin is considered structurally more homogeneous than
HS). Authors claimed overexpression EXT-2 elevates the
expression of NDST-1, leading to more extensive N-sulfation
on the polysaccharide. However, whether the interaction
recruited more NDST-1 molecules to the nonreducing end is
not completely ruled out. It is known that EXT2 is typically
present at the nonreducing end to elongate the polysaccharide.
If this is case, NDST-1 perhaps initiates the modification at the
nonreducing, and thus extends the size of N-S domain to
reduce the structural heterogeneity. Given the fact the modifi-
cation of NDST-1 is exclusively toward the reducing end, our
model suggests that the cluster of N-S domain should be longer
if the N-sulfation is initiated at the nonreducing end. Indeed,
structural analysis of the HS from various tissues indicated that
the size of N-S domain is longer than those N-S domains iden-
tified in the middle of polysaccharide (28).
NDST-1 contains bothN-deacetylase andN-sulfotransferase
domains. A recombinant protein comprising of only N-sulfo-
transferase activity sulfates the GlcNH2 residue regardless the
position in an oligosaccharide substrate or aGlcNS in the vicin-
ity (12). Our observation suggests that the substrate specificity
ofNDST-1 is dominated by the deacetylase domain; however, it
remains to be confirmed by studying the substrate specificity
of the recombinant protein carrying only the N-deacetylase
domain.Alternatively, both activities are required to exhibit the
full scale substrate specificity. It is also important to note that
NDST is present in multiple isoforms. Whether different iso-
forms have distinct capability of generating the N-S domains
andN-Ac is currently unknown. In addition, the core protein of
proteoglycans as well as potential molecular chaperons or the
supra molecular complex involved in HS biosynthetic enzymes
(27) may have direct or indirect impacts on the distribution of
domain structures in vivo. Despite its limitations, using struc-
turally defined oligosaccharide model substrates and MS tech-
nique certainly offer a new approach to delineate the substrate
specificities of NDSTs to reveal the biosynthetic mechanism of
HS.
REFERENCES
1. Bishop, J. R., Schuksz, M., and Esko, J. D. (2007) Nature 446,
1030–1037
2. Gama, C. I., Tully, S. E., Sotogaku, N., Clark, P. M., Rawat, M., Vaidehi, N.,
Goddard,W.A., 3rd, Nishi, A., andHsieh-Wilson, L. C. (2006)Nat. Chem.
Biol. 2, 467–473
3. Murphy, K. J., Merry, C. L., Lyon, M., Thompson, J. E., Roberts, I. S., and
Gallagher, J. T. (2004) J. Biol. Chem. 279, 27239–27245
4. Kreuger, J., Spillmann, D., Li, J. P., and Lindahl, U. (2006) J. Cell Biol. 174,
323–327
5. Esko, J. D., and Selleck, S. B. (2002) Annu. Rev. Biochem. 71, 435–471
6. Peterson, S. P., Frick, A., and Liu, J. (2009) Nat. Prod Rep. 26, 61–627
7. Aikawa, J., and Esko, J. D. (1999) J. Biol. Chem. 274, 2690–2695
8. Aikawa, J., Grobe, K., Tsujimoto, M., and Esko, J. D. (2001) J. Biol. Chem.
276, 5876–5882
9. Rong, J., Habuchi, H., Kimata, K., Lindahl, U., and Kusche-Gullberg, M.
(2001) Biochemistry 40, 5548–5555
10. Li, J. P., Gong, F., El Darwish, K., Jalkanen, M., and Lindahl, U. (2001)
J. Biol. Chem. 276, 20069–20077
11. Domon, B., and Costello, C. E. (1988) Glycoconj J. 5, 397–409
12. Liu, R., Xu, Y., Chen, M., Weïwer, M., Zhou, X., Bridges, A. S., DeAngelis,
P. L., Zhang, Q., Linhardt, R. J., and Liu, J. (2010) J. Biol. Chem. 285,
34240–34249
13. Forsberg, E., and Kjellen, L. (2001) J. Clin. Invest. 108, 175–180
14. Pallerla, S. R., Lawrence, R., Lewejohann, L., Pan, Y., Fischer, T., Scholo-
FIGURE 6. Mode of action of NDST-1. Panel A shows the scenario of the substrate without a GlcNS residue. NDST-1 can initiate the N-sulfation at any internal
GlcNAc residue, and the sulfation proceeds from nonreducing to reducing end. The N-sulfation stops at the residue that is five saccharide units away from the
reducing end. Panel B shows the scenario of the substrate with a GlcNS residue. The preexisting GlcNS residues prevent the N-sulfation immediately located at
the nonreducing end, leaving the gap between two GlcNS residues. The gap should be at least five saccharide units long.
Substrate Specificity of NDST-1
JUNE 3, 2011 • VOLUME 286 • NUMBER 22 JOURNAL OF BIOLOGICAL CHEMISTRY 19775
mann, U., Zhang, X., Esko, J. D., and Grobe, K. (2008) J. Biol. Chem. 283,
16885–16894
15. Fan, G., Xiao, L., Cheng, L.,Wang, X., Sun, B., andHu,G. (2000) FEBS Lett.
467, 7–11
16. MacArthur, J. M., Bishop, J. R., Stanford, K. I., Wang, L., Bensadoun, A.,
Witztum, J. L., and Esko, J. D. (2007) J. Clin. Invest. 117, 153–164
17. Crawford, B. E., Garner, O. B., J. R., B., Zhang, D. Y., K. T., B., Nigam, S. K.,
and Esko, J. D. (2010) PLOS One 5, 1–10
18. Wang, L., Fuster, M., Sriramarao, P., and Esko, J. D. (2005)Nat. Immunol.
6, 902–910
19. Fuster, M. M., Wang, L., Castagnola, J., Sikora, L., Reddi, K., Lee, P. H. A.,
Radek, K. A., Schuksz, M., Bishop, J. R., Gallo, R. L., Sriramarao, P., and
Esko, J. D. (2007) J. Cell Biol. 177, 539–549
20. Saribas, A. S.,Mobasseri, A., Pristatsky, P., Chen, X., Barthelson, R., Hakes,
D., and Wang, J. (2004) Glycobiology 14, 1217–1228
21. Duncan, M. B., Liu, M., Fox, C., and Liu, J. (2006) Biochem. Biophys. Res.
Commun. 339, 1232–1237
22. Sigulinsky, C., Babu, P., Victor, X. V., and Kuberan, B. (2010) Carbohydr
Res. 345, 250–256
23. Chen, J., Jones, C. L., and Liu, J. (2007) Chem. Biol. 14, 986–993
24. Chen, M., Bridges, A., and Liu, J. (2006) Biochemistry 45, 12358–12365
25. Sismey-Ragatz, A. E., D. E., G., Otto, N. J., Rejzek, M., Field, R. A., and
Deangelis, P. L. (2007) J. Biol. Chem. 282, 28321–28327
26. Carlsson, P., Presto, J., Spillmann, D., Lindahl, U., and Kjellen, L. (2008)
J. Biol. Chem. 283, 20008–20014
27. Presto, J., Thuveson, M., Carlsson, P., Busse, M., Willen, M., Eriksson, I.,
Kusche-Gullberg, M., and Kjellen, L. (2008) Proc. Natl. Acad. Sci. 105,
4751–4756
28. Staples, G. O., Shi, X., and Zaia, J. (2010) J. Biol. Chem. 285,
18336–18343
Substrate Specificity of NDST-1
19776 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 286 • NUMBER 22 • JUNE 3, 2011
